Hemorrhagic Complications of Transvaginal Oocyte's Retrieval: an Update.

Infertility Clinical Trial

Official title:

Hemorrhagic Complications of Transvaginal Oocyte's Retrieval: an Update.

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT05895227
• Other study ID #: 16/23
• Status: Completed
• Start date: January 1, 2017
• Est. completion date: December 21, 2022

Study information

• Verified date: May 2023
• Source: Istituto Clinico Humanitas
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

The goal of this retrospective analysis is to focus on peritoneal bleeding after oocyte retrieval and to further investigate factors related to this specific complication and if hemorrhagic complication rate modifications can be observed.

Description:

The main aim is to update our knowledge on oocyte retrieval complication, focusing specifically on hemorrhagic / hemoperitoneum rate.

All retrievals will be retrieved in IVF/ICSI cycles and Fertility Preservation both in oncological patients and in patients requesting oocyte storage for deferring motherhood.

Data collection goes from January 2017 to December 2022.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 13193
• Est. completion date: December 21, 2022
• Est. primary completion date: December 21, 2022
• Gender: Female
• Age group: 18 Years to 45 Years

Eligibility

Inclusion Criteria:

• patients that underwent a procedure of oocyte transvaginal retrieval for IVF/ intracytoplasmatic sperm injection (ICSI) cycles and fertility preservation

Exclusion Criteria:

-

Related Conditions & MeSH terms

• ART
• Infertility

Intervention

Procedure:
• Oocyte retrieval

Locations

Country	Name	City	State
n/a

Sponsors (1)

Lead Sponsor	Collaborator
Istituto Clinico Humanitas

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Hemoperitoneum after oocyte transvaginal retrieval	number of patients with onset of hemoperitoneum	Oocyte retrievals in the period January 2017- December 2022
Secondary	Operator of the procedure	assessment of operator experience	6 years
Secondary	Hemoglobin level before and after procedure	evaluation of hemoglobin level before and the day after procedure	6 years
Secondary	Time of symptoms onset	evaluation of first symptoms onset	6 years
Secondary	Loss of blood during procedure	average blood loss	6 years
Secondary	Incidence compared to past case history	comparison with previous statistic	6 years
Secondary	Need for hospitalization	patients requiring hospitalisation	6 years